Linda Cederblad

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The chemokine receptor CX3CR1 has been implicated as an attractive therapeutic target in several diseases, including atherosclerosis and diabetes. However, there has been a lack of non-peptide CX3CR1 inhibitors to substantiate these findings. A selective small-molecule inhibitor of CX3CR1, AZD8797, was recently reported and we present here an in-depth in(More)
  • 1